Location History:
- Somerset, NJ (US) (2002 - 2006)
- Summerset, NJ (US) (2002 - 2006)
Company Filing History:
2 out of 272 
1 out of 184 
2 out of 832,961 Years Active: 2002-2006
Title: An Insight into the Innovative Mind of Kevin Czaplinski
Introduction
Kevin Czaplinski, an inventive mind based in Summerset, NJ, has made significant contributions to the field of molecular biology through his innovative research and patents. With a portfolio of five patents, Czaplinski has focused on advancements that aid in understanding and manipulating the processes of translation termination and RNA decay.
Latest Patents
Czaplinski's latest patents showcase cutting-edge methods and compounds in the realm of RNA biology. One notable patent is for "Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay." This innovative application details methods for identifying compounds that can impede undesirable translation processes in cells.
Another significant patent pertains to "Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof." This patent presents a multiprotein complex capable of modulating peptidyl transferase activity during translation. The complex includes essential proteins such as the Modulator of Translation Termination protein (Mtt1p), Upf1 protein, and peptidyl eukaryotic release factors eRF1 and eRF3.
Career Highlights
Czaplinski has collaborated with leading organizations in his field to further his research. Notably, he has been associated with the University of Medicine and Dentistry of New Jersey, where his research has contributed significantly to the understanding of translation mechanisms. His academic background has provided a strong foundation for his innovative endeavors, pushing the boundaries of existing knowledge in molecular biology.
Collaborations
Throughout his career, Czaplinski has worked alongside prominent figures in the scientific community, including Stuart W. Peltz and Holger Beckmann. These collaborations have not only enriched his research but have also facilitated the exchange of ideas that propel innovation in the field of molecular biology.
Conclusion
Kevin Czaplinski stands out as a dedicated inventor whose innovative contributions to molecular biology are underscored by his valuable patents. His work has significantly advanced the understanding of translation processes, leading to potential new avenues for therapeutic development. As he continues to explore and innovate, Czaplinski's impact on the scientific community will undoubtedly persist.